60 Minutes Investigates Kratom: Legal Opioid Sold at Gas Stations Draws Lobbying Scrutiny

Multiple young men died after using kratom, including Matthew Eppard at 22, and users like Melanie Clark suffered addiction, hospitalization, and suicidal withdrawal.
A bag of chips is no harder to find than kratom
Kratom, an opioid-acting substance, is sold at tens of thousands of stores while federal policy shifts.
Mark

Why does this story land so hard? Kratom sounds like a wellness product.

Mimi

That's the point of it. Melanie Clark found it through an Instagram ad and a corner market, and she was addicted in about three weeks.

Mark

And the parents tell a similar story about how their sons started.

Mimi

Yes, coffee-family, safer than Red Bull, easing off alcohol. Each believed it was a supplement.

Luke

Let me separate things. Two of the four deaths list mitragynine alongside other drugs. Only Joe Chamberlain's and Matthew Eppard's were attributed solely to it.

Mimi

Right, and the toxicologist Justin Brower says he's seen dozens of kratom-only deaths.

Luke

Fair, but the tenfold rise is his estimate, not a CDC figure. The CDC number is more than 5,000 overdose deaths involving kratom since 2020.

Mark

What about the policy reversal?

Mimi

HHS moved from planning to restrict 7-OH to allowing 20 times more of it. Calley Means and Marty Makary both say they resigned partly over it.

Luke

Those are their accounts. HHS says contributions and pressure played no role, and Mullin denies lobbying. The reporting shows donations and lobbying spending, not proof of cause.

Mark

So what's solid?

Mimi

The pharmacology, the deaths, the money trail, and the 20-fold change. The motive is what's disputed.

  • A cheap bottle bought at a gas station quickly becomes a dependency that tightens its grip with every week of use.
  • Families are left sitting in parking lots and hospital halls after sons collapse, with causes of death tied to a substance sold as harmless.
  • Federal officials announced a plan to restrict 7-OH, then reversed course and raised allowable levels twentyfold, stirring alarm among health experts.
  • Lobbying dollars and political donations now sit at the center of the dispute, with resignations and denials fueling calls for scrutiny.
  • Watchers are waiting to see whether the 7-OH restrictions are revived and whether donor and lobbying records prompt formal review.

Across the American landscape, a plant long chewed in Southeast Asia has become a quiet fixture of gas station counters, sold as a gentle lift for tired bodies and anxious minds. Its strongest derivative, synthetic 7-OH, carries a potency that has left families grieving young men and has pulled users into addiction and despair. The question now hanging over Washington is whether public health caution or the persuasive weight of commerce will decide what reaches the shelves, and whether the people who paid the highest price will be heard.

Melanie Clark, an opera singer in Michigan, was struggling with postpartum depression and exhaustion in 2022 when Instagram ads for Feel Free, a plant-based energy drink, promised she could be a "SuperMom." At first the bottles delivered the lift she wanted. Within weeks she felt addicted and could not start her mornings without it. The drink's active ingredient, kratom, acts on the brain's opioid receptors, and the body converts part of it into 7-OH, which acts on those receptors even more strongly.

Across the country, families have been left to reckon with the cost. Four parents told 60 Minutes their sons had been drawn in by promises of coffee-like energy, a safer alternative to Red Bull, help leaving alcohol, or relief from anxiety. Matthew Eppard was 22 when he collapsed while playing cards with friends; his mother, Susan, remembers paramedics working to revive him and finding him cold and gray after she kissed his forehead. Toxicologists say kratom-related deaths have climbed sharply over the past decade, and the FDA itself warns of liver damage, seizures and addiction.

Clark's story took a darker turn. After she weaned off Feel Free she relapsed onto stronger 7-OH tablets, which sent her to the hospital. In withdrawal she experienced panic attacks and suicidal thoughts, and she ran from her home and over a fence when her husband called the police.

In July, federal health officials said they would restrict 7-OH. Last month that recommendation was reversed, and the allowable amount was raised twentyfold, surprising many in public health. Former officials have said industry pressure shaped the decision, and records show years of lobbying by the American Kratom Association alongside large political donations from the maker of Feel Free. HHS and the companies deny that contributions or pressure changed the outcome. What comes next is uncertain: whether the 7-OH restrictions return to the agenda, and whether the money and influence behind them draw the scrutiny the families are asking for.

Melanie Clark, a trained opera singer in Michigan, was dealing with post-partum depression and exhaustion in 2022 when Instagram showed her ads for Feel Free Classic Tonic, a plant-based energy drink. The pitch included the line "Feel Free to be SuperMom." She bought bottles for about $10 each at gas stations and a corner market near her home. At first, she told 60 Minutes, it more than met her hopes for a boost. She felt as if she had superpowers. Within about three weeks, she said, she felt addicted and needed the drink just to get going in the morning.

The active ingredient in Feel Free is kratom, derived from a tree native to Southeast Asia, where people have long chewed the leaves or boiled them into a stimulating tea with opioid effects. In the United States it has become a billion-dollar industry, sold online and in tens of thousands of stores as leaf powder, capsules, gummies, extracts and drinks. Supporters pitch it as a mild stimulant and even an aid in recovering from opioid addiction. It remains legal in most states.

Dr. Andrew Kolodny, medical director of the Opioid Policy Research Collaborative at Brandeis University, says its effects resemble those of oxycodone, heroin and even fentanyl. The main compound, mitragynine, activates opioid receptors in the brain, and the body converts some of it into 7-OH, which activates those receptors more intensely. Kolodny said he was struck that nearly everyone he saw who had developed an opioid addiction in recent years had gotten there through kratom.

Four parents told 60 Minutes their sons began using it because of the promised benefits. One thought it was like coffee, having read it came from the coffee family. Another was told by a friend it was safer than Red Bull. A third said it was helping him ease away from alcohol, and a fourth was seeking a natural way to manage anxiety. The causes of death for Daniel Bregger and Wyatt Wheeler list mitragynine alongside prescription and over-the-counter medications. The deaths of Joe Chamberlain and Matthew Eppard were attributed solely to mitragynine. Matthew was 22 and playing cards with friends when he collapsed. His mother, Susan Eppard, described sitting outside screaming while paramedics tried to revive him, and then kissing his forehead and finding him cold and gray.

The American Kratom Association, a consumer advocacy and lobbying group, calls natural kratom a safe food. Its public voice, Mac Haddow, told a congressional briefing in June 2026 that no known dose of mitragynine or kratom would cause a death. Haddow was convicted of felony ethics violations from the 1980s, when he was chief of staff at HHS. Justin Brower, a toxicologist at NMS Labs near Philadelphia who has analyzed thousands of kratom-related death cases, called that claim untrue. He has seen dozens and dozens of deaths attributed to kratom alone. Since 2020, the CDC has identified more than 5,000 overdose deaths involving kratom, and Brower estimated fatalities have risen roughly tenfold from 2014 into 2026. The FDA itself warns of liver toxicity, seizures and substance use disorder.

The FDA issued an import alert on kratom in 2014, yet millions of pounds, mostly from Indonesia, still arrive monthly labeled as items like cosmetics and incense. Newer products contain concentrated synthetic 7-OH, in tablets and liquid shots more potent than morphine, nicknamed "gas station heroin." Toxicologist Alex Krotulski of the Center for Forensic Science Research and Education said users chasing a high as tolerance grows shift to stronger drugs, and 7-OH is about ten times more potent than mitragynine.

Clark followed that path. After weaning off Feel Free, she relapsed and last year began taking 7-OH tablets from another company, which landed her in the hospital. In withdrawal she had panic attacks and became suicidal; her husband called the police, and she ran across the yard and hopped a fence. She told Jon Wertheim that is what addiction does.

In July, the federal government announced it intended to restrict 7-OH and three related substances, which Health Secretary Robert F. Kennedy Jr. called dangerous opioids. Last month, HHS reversed its recommendation and raised the amount of 7-OH allowed in products 20-fold, stunning some health officials. Calley Means, until recently a senior HHS advisor, said on Joe Rogan's podcast that the lobbying was unrelenting, including pressure from the West Wing. 60 Minutes found a decade of public filings showing steady lobbying money, much from the American Kratom Association, aimed at the FDA, HHS, the White House and Congress. Botanic Tonics, Feel Free's maker, and its founder J.W. Ross, a convicted felon, gave nearly $1.2 million to Kennedy's campaigns and the Make America Healthy Again PAC. Homeland Security Secretary Markwayne Mullin disclosed an investment of up to $1 million in the company; he confirmed it but denied lobbying. Botanic Tonics did not respond.

Means and Dr. Marty Makary, the former FDA head, both said they resigned partly over kratom policy they say was shaped by business interests. HHS said neither contributions nor outside pressure influenced its recommendation. The AKA distinguished natural kratom from "dangerous chemically manipulated products." Kolodny sees an old playbook, noting that some scientists Purdue Pharma hired to head off OxyContin regulation now work for the Kratom Association. Asked about kratom for the nearly 10 million Americans with opioid use disorder, he said simply: don't use it, because the evidence is not there. What to watch next is whether 7-OH scheduling is revived and whether the lobbying and donation records draw review.

Don't use kratom; for opioid use disorder, the evidence isn't there.
— Dr. Andrew Kolodny, Brandeis University
Neither political contributions nor outside pressure influenced our recommendation.
— HHS statement
Vuoi la storia completa? Leggi l'originale su CBS News ↗
Contattaci Domande frequenti